Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2005 Filed Oct 3, 2005 23:27 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 542 | $42.40 Strike: $0.00 | $22,980.80 |
DisclosureSEC source: 0001104659-05-046917 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,931 Underlying: common shares · 542 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| August 01, 2005 Filed Aug 2, 2005 21:01 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 4,271 | $46.91 | $200,352.61 |
DisclosureSEC source: 0001104659-05-035725 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,366 Read SEC document |
| July 01, 2005 Filed Jul 6, 2005 20:19 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Tax withholdingCommon shares without par value | 31,923 | $49.31 | $1,573,963.52 |
DisclosureSEC source: 0001104659-05-031355 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,054 Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 19:05 UTC |
RAND A BARRYDirector
|
GrantStock equivalent units · Derivative | 244 | $49.01 Strike: $0.00 | $11,958.44 |
DisclosureSEC source: 0001104659-05-030983 · a4.xml · derivative · entry 1 RAND A BARRY · CIK 0001012979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 972 Underlying: common shares · 244 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 19:04 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 469 | $49.01 Strike: $0.00 | $22,985.69 |
DisclosureSEC source: 0001104659-05-030981 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,292 Underlying: common shares · 469 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 19:05 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 255 | $49.01 Strike: $0.00 | $12,497.55 |
DisclosureSEC source: 0001104659-05-030982 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,680 Underlying: common shares · 255 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 20:19 UTC |
REYNOLDS W ANNDirector
|
GrantStock equivalent units · Derivative | 469 | $49.01 Strike: $0.00 | $22,985.69 |
DisclosureSEC source: 0001104659-05-031010 · a4.xml · derivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,175 Underlying: common shares · 469 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 20:19 UTC |
ROBERTS ROY SDirector
|
GrantStock equivalent units · Derivative | 408 | $49.01 Strike: $0.00 | $19,996.08 |
DisclosureSEC source: 0001104659-05-031011 · a4.xml · derivative · entry 1 ROBERTS ROY S · CIK 0001200813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408 Underlying: common shares · 408 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 20:20 UTC |
DALEY WILLIAM MDirector
|
GrantStock equivalent units · Derivative | 408 | $49.01 Strike: $0.00 | $19,996.08 |
DisclosureSEC source: 0001104659-05-031012 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Underlying: common shares · 408 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 21:11 UTC |
Schumacher Laura JSenior Vice President
|
GrantOption (right to buy) · Derivative | 6,885 | $0.00 Strike: $49.08 | $0.00 |
DisclosureSEC source: 0001104659-05-029113 · a4.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,885 Underlying: Common shares · 6,885 shares Expires 2013-02-13 F1 · security: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on May 25, 2005. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 21:11 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,558 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-029113 · a4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,364 Underlying: common shares · 8,558 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on May 25, 2005. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 21:11 UTC |
Schumacher Laura JSenior Vice President
|
Tax withholdingCommon shares without par value | 6,885 | $49.08 | $337,915.80 |
DisclosureSEC source: 0001104659-05-029113 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,544 Read SEC document |
| June 17, 2005 Filed Jun 21, 2005 21:11 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 8,558 | $33.23 | $284,394.32 |
DisclosureSEC source: 0001104659-05-029113 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on May 25, 2005. Read SEC document |
| June 07, 2005 Filed Jun 9, 2005 19:02 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantOption (right to buy) · Derivative | 19,944 | $0.00 Strike: $48.45 | $0.00 |
DisclosureSEC source: 0001104659-05-027522 · a4.xml · derivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,944 Underlying: common shares · 19,944 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 07, 2005 Filed Jun 9, 2005 19:02 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 24,629 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-027522 · a4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,421 Underlying: common shares · 24,629 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 07, 2005 Filed Jun 9, 2005 19:02 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Tax withholdingCommon shares without par value | 19,944 | $48.45 | $966,286.80 |
DisclosureSEC source: 0001104659-05-027522 · a4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,977 Read SEC document |
| June 07, 2005 Filed Jun 9, 2005 19:02 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionCommon shares without par value | 24,629 | $33.23 | $818,456.15 |
DisclosureSEC source: 0001104659-05-027522 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 10,642 | $0.00 Strike: $48.33 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 Underlying: common shares · 10,642 shares Expires 2010-02-10 F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,251 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,584 Underlying: common shares · 13,251 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 10,642 | $48.33 | $514,327.86 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,781 F2 · kind: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 13,251 | $32.61 | $432,129.69 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 34,800 | $0.00 Strike: $48.32 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,800 Underlying: common shares · 34,800 shares Expires 2015-05-31 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under rule 16b-3. The option becomes exercisable in annual increments of 11,600 on 06/01/06, 11,600 on 06/01/07, and 11,600 on 06/01/08. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 17:57 UTC |
Fussell Stephen RSenior Vice President
|
GrantCommon shares without par value | 15,200 | $48.32 | $734,464.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,172 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| May 25, 2005 Filed May 26, 2005 20:33 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
GrantOption (right to buy) · Derivative | 22,916 | $0.00 Strike: $48.67 | $0.00 |
DisclosureSEC source: 0001104659-05-025641 · a4.xml · derivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 Underlying: common shares · 22,916 shares Expires 2007-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 25, 2005 Filed May 26, 2005 20:33 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 26,251 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0001104659-05-025641 · a4.xml · derivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 26,251 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 25, 2005 Filed May 26, 2005 20:33 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Tax withholdingCommon shares without par value | 22,916 | $48.67 | $1,115,321.72 |
DisclosureSEC source: 0001104659-05-025641 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,941 Read SEC document |
| May 25, 2005 Filed May 26, 2005 20:33 UTC |
DEMPSEY WILLIAM GSenior Vice President
|
Exercise / conversionCommon shares without par value | 26,251 | $38.46 | $1,009,526.83 |
DisclosureSEC source: 0001104659-05-025641 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2005 Filed Aug 4, 2005 14:43 UTC |
Landgraf John CSenior Vice President
|
GiftCommon Shares without par value | 18,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-036273 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Ann Marie Landgraf Living Trust Disclosed balance after: 20,000 F1 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. Read SEC document |
| May 25, 2005 Filed Aug 4, 2005 14:43 UTC |
Landgraf John CSenior Vice President
|
GiftCommon Shares without par value | 18,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-036273 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,918 Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC |
NEMMERS JOSEPH MSenior Vice President
|
GrantOption (right to buy) · Derivative | 9,162 | $0.00 Strike: $49.02 | $0.00 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,162 Underlying: common shares · 9,162 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,381 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,583 Underlying: common shares · 11,381 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Tax withholdingCommon shares without par value | 9,162 | $49.02 | $449,121.24 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,723 Read SEC document |
| May 09, 2005 Filed May 11, 2005 20:01 UTC |
NEMMERS JOSEPH MSenior Vice President
|
Exercise / conversionCommon shares without par value | 11,381 | $33.23 | $378,206.56 |
DisclosureSEC source: 0001104659-05-022562 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2005 Filed May 3, 2005 20:35 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 9,666 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-05-020007 · a4.xml · derivative · entry 5 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,666 Underlying: common shares · 9,666 shares Expires 2015-04-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 01, 2005 Filed May 3, 2005 20:35 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 9,667 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-05-020007 · a4.xml · derivative · entry 4 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Underlying: common shares · 9,667 shares Expires 2015-04-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 01, 2005 Filed May 3, 2005 20:35 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 9,667 | $0.00 Strike: $48.66 | $0.00 |
DisclosureSEC source: 0001104659-05-020007 · a4.xml · derivative · entry 3 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Underlying: common shares · 9,667 shares Expires 2015-04-30 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 01, 2005 Filed May 3, 2005 20:35 UTC |
Tyree James LSenior Vice President
|
GrantCommon shares without par value | 14,100 | $48.66 | $686,106.00 |
DisclosureSEC source: 0001104659-05-020007 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,603 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:24 UTC |
AUSTIN ROXANNE SDirector
|
GrantCommon Shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018221 · a4.xml · nonDerivative · entry 1 AUSTIN ROXANNE S · CIK 0001061632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,733 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
SMITHBURG WILLIAM DDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018222 · a4.xml · nonDerivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,896 F1 · security: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the -earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the -earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
DALEY WILLIAM MDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018225 · a4.xml · nonDerivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,889 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
WALTER JOHN RDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018226 · a4.xml · nonDerivative · entry 1 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,475 F1 · security: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
REYNOLDS W ANNDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018224 · a4.xml · nonDerivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,875 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid in Abbott common shares, on a one-to-one basis, on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
ROBERTS ROY SDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018228 · a4.xml · nonDerivative · entry 1 ROBERTS ROY S · CIK 0001200813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,381 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
GREENBERG JACK MDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018227 · a4.xml · nonDerivative · entry 1 GREENBERG JACK M · CIK 0001074611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,733 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid on a one-to-one basis in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
FULLER H LAURANCEDirector
|
GrantOption (right to buy) · Derivative | 5,796 | $0.00 Strike: $47.62 | $0.00 |
DisclosureSEC source: 0001104659-05-018229 · a4.xml · derivative · entry 2 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,796 Underlying: Common shares · 5,796 shares Expires 2015-04-20 F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program. Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:25 UTC |
FULLER H LAURANCEDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018229 · a4.xml · nonDerivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,523 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:26 UTC |
POWELL BOONE JRDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018231 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,046 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined the Program). Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:26 UTC |
OWEN DAVIDDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018230 · a4.xml · nonDerivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,255 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| April 22, 2005 Filed Apr 26, 2005 21:26 UTC |
RAND A BARRYDirector
|
GrantCommon shares without par value | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-018232 · a4.xml · nonDerivative · entry 1 RAND A BARRY · CIK 0001012979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,662 F1 · security: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program). F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11. Read SEC document |
| April 20, 2005 Filed May 17, 2005 20:41 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-024133 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,637 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.